A small study on patients with metastatic melanoma who were treated with autologous vaccines in a phase 2 clinical trial suggests that soluble PD-1 may have potential as a prognostic biomarker.
Deficits in use of sunscreen indicate that people pay little attention to the recommendations of health authorities, regardless of their skin type, and underscore an urgent need for targeted public information on its use.
From 2012 to 2014, 41,185 patients with a diagnosis of skin malignancy of the head and neck region were identified, mostly with a diagnosis of nonmelanoma skin cancer.
For nonelderly adults in the United States, having Medicaid or no health insurance is associated with increased odds of being diagnosed with late-stage melanoma compared with having private insurance.
Researchers evaluated the risk for nonmelanoma skin cancer in patients receiving anti-tumor necrosis factor (TNF) inhibitors vs those who did not receive anti-TNFs.
Diagnosis and management of EF in the setting of cancer immunotherapy requires close collaboration between patient’s oncologist, dermatologist, and rheumatologist.
Clinical factors such as history of solid organ transplantation, presence of diabetes, history of other malignancies, and poor histologic differentiation were significant risk factors for recurrence of cutaneous SCC in Asian patients treated with Mohs surgery.
A strong influence of progestogens used before menopause on melanoma risk was not supported by novel study results, nor do they support a phototoxic effect of progestogens in melanoma risk.
Cosmetic outcomes are best in patients with skin cancer who receive brachytherapy or Mohs micrographic surgery, suggest results from a novel study comparing cosmetic and cancer control outcomes of surgical and radiotherapeutic modalities.
